These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 33941564

  • 1. Comparison of the Siemens Atellica BRAHMS and the Abbott Architect BRAHMS Procalcitonin Assays.
    Walker C, Shuster A, Weber C, Gebhardt K, Scheidegger M, Swartzwelder J, Williams J, Li J.
    Ann Clin Lab Sci; 2021 Mar; 51(2):241-244. PubMed ID: 33941564
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays.
    Wang D, Caddell B, Nolte FS, Babic N.
    J Appl Lab Med; 2019 Jan; 3(4):580-586. PubMed ID: 31639727
    [Abstract] [Full Text] [Related]

  • 3. Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays.
    Lippi G, Salvagno GL, Gelati M, Pucci M, Lo Cascio C, Demonte D, Faggian D, Plebani M.
    Clin Chem Lab Med; 2019 Dec 18; 58(1):77-84. PubMed ID: 31539351
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of procalcitonin assay on the Abbott Architect i2000 SR® analyzer].
    El Mouatani A, Rotaru I, Beaudeux JL, Hennequin C.
    Ann Biol Clin (Paris); 2018 Jun 01; 76(3):308-312. PubMed ID: 29622524
    [Abstract] [Full Text] [Related]

  • 5. Validation of the Procalcitonin Assay on the Abbott Architect i1000.
    Pagaduan JV, Tam E, Devaraj S.
    J Appl Lab Med; 2019 May 01; 3(6):936-942. PubMed ID: 31639685
    [Abstract] [Full Text] [Related]

  • 6. Multicenter comparison of automated procalcitonin immunoassays.
    Dipalo M, Guido L, Micca G, Pittalis S, Locatelli M, Motta A, Bianchi V, Callegari T, Aloe R, Da Rin G, Lippi G.
    Pract Lab Med; 2015 Aug 01; 2():22-28. PubMed ID: 28932801
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of procalcitonin immunoassay concordance near clinical decision points.
    Chambliss AB, Hayden J, Colby JM.
    Clin Chem Lab Med; 2019 Aug 27; 57(9):1414-1421. PubMed ID: 30763263
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems.
    Soh A, Binder L, Clough M, Hernandez MH, Lefèvre G, Mostert K, Nguyen TB, Otte KM, Portakal O, Sandri MS, Yen JL, Huang J, Beshiri A.
    Pract Lab Med; 2018 Nov 27; 12():e00110. PubMed ID: 30519621
    [Abstract] [Full Text] [Related]

  • 9. Method Verification Shows a Negative Bias between 2 Procalcitonin Methods at Medical Decision Concentrations.
    Gruzdys V, Cahoon K, Pearson L, Lehman CM.
    J Appl Lab Med; 2019 Jul 27; 4(1):69-77. PubMed ID: 31639709
    [Abstract] [Full Text] [Related]

  • 10. Concordance of Three Automated Procalcitonin Immunoassays at Medical Decision Points.
    Cho HW, Kim SH, Cho Y, Jeong SH, Lee SG.
    Ann Lab Med; 2021 Jul 01; 41(4):419-423. PubMed ID: 33536362
    [Abstract] [Full Text] [Related]

  • 11. Analytical evaluation of the novel Lumipulse G BRAHMS procalcitonin immunoassay.
    Ruzzenente O, Salvagno GL, Gelati M, Lippi G.
    Pract Lab Med; 2016 Dec 01; 6():8-13. PubMed ID: 28856208
    [Abstract] [Full Text] [Related]

  • 12. As a Novel Procalcitonin Assay is Architect B∙R∙A∙H∙M∙S PCT; Comparison of Two Commercial Systems.
    Aydemir Ö, Karakeçe E, Köroğlu M, Aydemir Y, Terzi HA, Erkorkmaz Ü, Altindiş M.
    Clin Lab; 2019 Apr 01; 65(4):. PubMed ID: 30969065
    [Abstract] [Full Text] [Related]

  • 13. Comparison of a novel automated DiaSys procalcitonin immunoassay with four different BRAHMS-partnered immunoassays.
    Eidizadeh A, Wiederhold M, Schnelle M, Binder L.
    Pract Lab Med; 2022 May 01; 30():e00274. PubMed ID: 35465623
    [Abstract] [Full Text] [Related]

  • 14. Analytical performance comparing siemens whole blood point of care Atellica VTLi to the central laboratory plasma Atellica IM high-sensitivity cardiac troponin I assays.
    Xiong-Hang K, Schulz K, Sandoval Y, Smith SW, Saenger AK, Apple FS.
    Clin Biochem; 2023 Apr 01; 114():79-85. PubMed ID: 36780933
    [Abstract] [Full Text] [Related]

  • 15. Analytical Evaluation of Point-of-Care Finecare™ Procalcitonin Rapid Quantitative Test in Sepsis Population as Compared with Elecsys® BRAHMS Procalcitonin Immunoassay.
    Mazlan MZ, Wan Azman WN, Yaacob NM, Koon TS, Yahya NK.
    Diagnostics (Basel); 2024 May 22; 14(11):. PubMed ID: 38893607
    [Abstract] [Full Text] [Related]

  • 16. Analytical evaluation of the novel VITROS BRAHMS procalcitonin immunoassay.
    Dupuy AM, Bargnoux AS, Montagnon V, Kuster N, Badiou S, Cristol JP.
    Scand J Clin Lab Invest; 2020 Nov 22; 80(7):541-545. PubMed ID: 33124916
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of a new procalcitonin assay for the Siemens ADVIA Centaur with the established method on the B.R.A.H.M.S Kryptor.
    Sanders RJ, Schoorl M, Dekker E, Snijders D, Boersma WG, Ten Boekel E.
    Clin Lab; 2011 Nov 22; 57(5-6):415-20. PubMed ID: 21755834
    [Abstract] [Full Text] [Related]

  • 18. Analytical and clinical performance of the Advansure i3 procalcitonin assay.
    Heo W, Park HD.
    Scand J Clin Lab Invest; 2021 Nov 22; 81(7):546-551. PubMed ID: 34601986
    [Abstract] [Full Text] [Related]

  • 19. A new sensitive automated assay for procalcitonin detection: LIAISON® BRAHMS PCT® II GEN.
    Fortunato A.
    Pract Lab Med; 2016 Dec 01; 6():1-7. PubMed ID: 28856207
    [Abstract] [Full Text] [Related]

  • 20. Comparison of Direct and Extraction Immunoassay Methods With Liquid Chromatography-Tandem Mass Spectrometry Measurement of Urinary Free Cortisol for the Diagnosis of Cushing's Syndrome.
    Mu D, Fang J, Yu S, Ma Y, Cheng J, Hu Y, Song A, Zhao F, Zhang Q, Qi Z, Zhang K, Xia L, Qiu L, Zhu H, Cheng X.
    Ann Lab Med; 2024 Jan 01; 44(1):29-37. PubMed ID: 37665283
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.